Urinary tract infection and Myelodysplastic syndrome

Summary:

Myelodysplastic syndrome is found among people with Urinary tract infection, especially for people who are female, 60+ old.

The study analyzes which people have Myelodysplastic syndrome with Urinary tract infection. It is created by eHealthMe based on reports of 21 people who have Urinary tract infection from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,956 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

What is Myelodysplastic syndrome?

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged) is found to be associated with 826 drugs and 1,110 conditions by eHealthMe. Check the latest studies of Myelodysplastic syndrome.

On Jul, 17, 2026

21 people who have Urinary Tract Infection and Myelodysplastic Syndrome are studied.

Would you have Myelodysplastic syndrome when you have Urinary tract infection?

Gender of people who have Urinary Tract Infection and experienced Myelodysplastic Syndrome *:

female: 90 %
male: 10 %

Age of people who have Urinary Tract Infection and experienced Myelodysplastic Syndrome *:

Common co-existing conditions for these people *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 23.81%
Insomnia (sleeplessness): 5 people, 23.81%
Pain: 5 people, 23.81%
Infection: 3 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 14.29%
Multiple Myeloma (cancer of the plasma cells): 3 people, 14.29%
Nausea (feeling of having an urge to vomit): 3 people, 14.29%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 9.52%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 9.52%
High Blood Cholesterol: 2 people, 9.52%

Common drugs taken by these people *:

Zofran: 3 people, 14.29%
Revlimid: 3 people, 14.29%
Soliris: 2 people, 9.52%
Fosfomycin Tromethamine: 2 people, 9.52%
Neurontin: 2 people, 9.52%
Nexium: 2 people, 9.52%
Paracetamol: 2 people, 9.52%
Plerixafor: 2 people, 9.52%
Premarin: 2 people, 9.52%
Cytoxan: 2 people, 9.52%

Common symptoms for these people *:

Fatigue (feeling of tiredness): 3 people, 14.29%
Nausea (feeling of having an urge to vomit): 3 people, 14.29%
Anaemia (lack of blood): 3 people, 14.29%
Headache (pain in head): 3 people, 14.29%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 9.52%
Chills (felling of cold): 2 people, 9.52%
Pain: 2 people, 9.52%
Pneumonia: 2 people, 9.52%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 2 people, 9.52%
Blood Glucose Increased: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Myelodysplastic syndrome?

- Check whether Myelodysplastic syndrome is associated with a drug or a condition

Related publications that referenced our studies

Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Myelodysplastic syndrome and Urinary tract infection, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.